Together with RIEMSER's internationally experienced and highly qualified employees, our management works to implement the company's growth strategy.

Konstantin von Alvensleben

Konstantin von Alvensleben was appointed Chairman of the RIEMSER management board with effect from the 1st of June 2015.

As the Managing Director of Schwarz Pharma France, England and Germany, Mr. von Alvensleben has successfully shaped the development of Schwarz Pharma within these markets, especially in the areas of Business Development and In-licensing as well as Marketing and Sales. Following the takeover of Schwarz Pharma by UCB, he has, as Managing Director of UCB in Germany and Managing Director of Takeda since 2009, gained extensive experience of both the national and international pharmaceutical business.

Dr. Uwe Salzer

CFO of RIEMSER Pharma GmbH since 1 September 2016.

Between 2011 and 2015, Dr. Salzer held the position of Chief Financial Officer at CABB GmbH in Sulzbach am Taunus and also fulfilled the same role at HC Starck in Goslar between 2008 and 2010. Prior to 2008, he held senior positions at Degussa (now Evonik), including CFO at Degussa Corporation in the USA. He is a recognized expert in his field and possesses extensive entrepreneurial knowledge and experience. Dr. Salzer has already acted in a consulting role to RIEMSER Pharma GmbH before.